UnknownNCT03096496
Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy
Studying Acute promyelocytic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Principal Investigator
- Fabio EfficaceGIMEMA Foundation
- Intervention
- QoL questionnaires(other)
- Enrollment
- 161 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2022
Study locations (16)
- UOC Ematologia e Terapia Cellulare - Ospedale C. e G. Mazzoni di Ascoli Piceno, Ascoli Piceno, Italy
- Spedali Civili - Brescia - Azienda Ospedaliera - U.O. Ematologia, Brescia, Italy
- Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze MEdiche Sezione di Ematologia e Fisiopatologia dell'Emostasi, Cona, Italy
- AOU - Policlinico G. Martino Messina Medicine Specialistiche e Oncologia Medica - UOC Ematologia, Messina, Italy
- Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico, Milan, Italy
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia - Padiglione Marcora 2do piano, Milan, Italy
- UO Ematologia e Trapiano di Midollo - Ist. Scientifico Ospedale San Raffaele, Milan, Italy
- UO Ematologia - AOU Policlinico di Modena, Modena, Italy
- SCDU Medicina Interna a indirizzo ematologico, Orbassano, Italy
- U.O. di Oncoematologia -plesso ospedaliero "A. Tortora" di Pagani, Pagani, Italy
- Ospedali Riuniti "Villa Sofia-Cervello", Palermo, Italy
- S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
- Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy
- Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
- Ematologia - Dipartimento di Medicina Clinica e Sperimentale, Sassari, Italy
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03096496 on ClinicalTrials.govOther trials for Acute promyelocytic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07563179Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaShenzhen University General Hospital
- RECRUITINGPHASE3NCT07504458Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaQuetzal Therapeutics
- RECRUITINGPHASE3NCT07223814Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)Stichting Hemato-Oncologie voor Volwassenen Nederland
- ACTIVE NOT RECRUITINGNANCT07187505Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic LeukemiaAnhui Medical University
- RECRUITINGPHASE3NCT07503730Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).First Affiliated Hospital Xi'an Jiaotong University
- ENROLLING BY INVITATIONNANCT06697327Daunorubicin + Cytarabine + Venetoclax in de Novo AMLAnhui Medical University
- RECRUITINGPHASE1NCT06313437Revumenib in Combination With 7+3 + Midostaurin in AMLRichard Stone, MD
- RECRUITINGPHASE3NCT06578247Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AMLDaiichi Sankyo